![81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials]()
81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trialsN. Beaulieu; I. Dupont; C. Beaulieu; H. Nguyen; H. Ste-Croix; S. Claridge; L. Isakovic; A. Vaisburg; J.M. Besterman; C. Maroun · 2008